The use of insulin in elderly patients with type 2 diabetes mellitus

被引:7
作者
Mannucci, Edoardo [1 ]
Cremasco, Francesco [2 ]
Romoli, Ester [2 ]
Rossi, Andrea [2 ]
机构
[1] Careggi Teaching Hosp, Diabet Agcy, Florence, Italy
[2] Eli Lilly Italia, Sesto Fiorentino, FI, Italy
关键词
elderly; insulin; type; 2; diabetes; ORAL ANTIDIABETIC DRUGS; PREMIXED INSULIN; CLINICAL-TRIAL; BASAL INSULIN; OPEN-LABEL; ASPART; 30; MANAGEMENT; THERAPY; EFFICACY; ANALOGS;
D O I
10.1517/14656566.2011.633512
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Older patients with diabetes sometimes present comorbidities that increase the risk of other common geriatric syndromes. In such patients, treatment with insulin is usually started when full doses of oral hypoglycemic agents are no longer adequate to achieve acceptable glycemic control. Areas covered: This article reviews the available literature on the use of insulin in elderly patients with type 2 diabetes. The aims are to gain information on: the benefits and risks of initiating insulin treatment, the efficacy and safety of different types of insulin and the most appropriate initial dosing and titration regimens. Thirteen published trials have evaluated the effects of different insulin regimens in the management of elderly subjects with type 2 diabetes but, given that older people are generally excluded in clinical studies with insulin, only three published reports on subgroup analyses are limited to elderly patients. Expert opinion: The available literature shows that the addition of insulin to current oral treatments is generally safe and effective in improving metabolic control, with a low risk for hypoglycemia. Further research is needed to better understand the most appropriate insulin regimens necessary to achieve glycemic goals while appropriately addressing the risk of hypoglycemia.
引用
收藏
页码:2865 / 2881
页数:17
相关论文
共 47 条
[1]   Standards of medical care in diabetes 2008 [J].
不详 .
DIABETES CARE, 2008, 31 :S12-S54
[2]  
American Diabetes Association, 2010, DIABETES CARE S1, V33, pS42, DOI DOI 10.2337/DC10-S062
[3]  
[Anonymous], COMP PHARMACODYNAMIC
[4]  
[Anonymous], 2008, Can J Diabetes, V32, pS1, DOI DOI 10.1503/CMAJ.080554
[5]   A COMPARISON OF PREMIXED INSULIN PREPARATIONS IN ELDERLY PATIENTS - EFFICACY OF 70/30 AND 50/50 HUMAN INSULIN MIXTURES [J].
BRODOWS, R ;
CHESSOR, R .
DIABETES CARE, 1995, 18 (06) :855-857
[6]   Management of diabetes mellitus in the elderly [J].
Chiniwala, Niyati ;
Jabbour, Serge .
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2011, 18 (02) :148-152
[7]   Beta cell function declines with age in glucose tolerant Caucasians [J].
Chiu, KC ;
Lee, NP ;
Cohan, P ;
Chuang, LM .
CLINICAL ENDOCRINOLOGY, 2000, 53 (05) :569-575
[8]  
*EUR DIAB WORK PAR, CLIN GUID TYP 2 DIAB
[9]  
Funnell MM, 2008, INSULIN, V3, P31, DOI DOI 10.1016/S1557-0843(08)80009-7
[10]  
Galic E, 2005, MED SCI MONITOR, V11, pPI87